Home

Orbimed Advisors reported a 7.2% stake in Scribe Therapeutics SCTX · 1,348,825 sh

Trade details

Type
5% stake report
Report
13D
Stake
7.2%
Last report
First report
Shares held
1,348,825 sh
Class
Common Stock
Event date
26/07/27
Filed
26/07/29

First 5%+ report · 7.2% stake

Scribe Therapeutics trades, last 26 weeks

What else happened in Scribe Therapeutics around then

Filed or reported within 30 days of the trade day · 06/27~08/26

Orbimed Advisors's other 5% stake reports

  • Orbimed Advisors

    5% stakeElectra Therapeutics

    11% stake

    Filed 09/25

  • Orbimed Advisors

    5% stakeBraveheart Bio

    13.5% stake

    Filed 09/10

  • Orbimed Advisors

    5% stakeBraveheart Bio

    17.2% stake

    Filed 08/18

  • Orbimed Advisors

    5% stakeBlossomHill Therapeutics

    8.9% stake

    Filed 08/18

  • Orbimed Advisors

    5% stakeWhitehawk Therapeutics

    7.3% stake

    Filed 08/14